14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:NVLS
Delisted

Nivalis Therapeutics Fund Price (Quote)

$2.40
+0 (+0%)
At Close: Aug 09, 2017

Range Low Price High Price Comment
30 days $2.30 $2.44 Wednesday, 9th Aug 2017 NVLS stock ended at $2.40. During the day the stock fluctuated 4.72% from a day low at $2.33 to a day high of $2.44.
90 days $2.15 $2.51
52 weeks $2.00 $9.35

Historical Nivalis Therapeutics prices

Date Open High Low Close Volume
Aug 09, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Aug 08, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Aug 07, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Aug 04, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Aug 03, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Aug 02, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Aug 01, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Jul 31, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Jul 28, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Jul 27, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Jul 26, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Jul 25, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Jul 24, 2017 $2.35 $2.44 $2.33 $2.40 25 377
Jul 21, 2017 $2.40 $2.41 $2.30 $2.35 44 962
Jul 20, 2017 $2.41 $2.41 $2.32 $2.39 75 053
Jul 19, 2017 $2.33 $2.41 $2.30 $2.32 16 937
Jul 18, 2017 $2.38 $2.42 $2.30 $2.35 38 547
Jul 17, 2017 $2.38 $2.42 $2.35 $2.37 17 942
Jul 14, 2017 $2.40 $2.40 $2.33 $2.38 66 833
Jul 13, 2017 $2.44 $2.44 $2.32 $2.39 39 366
Jul 12, 2017 $2.43 $2.44 $2.35 $2.42 6 918
Jul 11, 2017 $2.40 $2.44 $2.39 $2.41 32 345
Jul 10, 2017 $2.42 $2.44 $2.36 $2.39 61 183
Jul 07, 2017 $2.40 $2.44 $2.38 $2.41 15 945
Jul 06, 2017 $2.37 $2.44 $2.36 $2.40 19 511
Click to get the best stock tips daily for free!

About Nivalis Therapeutics

Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of product candidates for patients with cystic fibrosis (CF). CF is a life-shortening genetic disease. Its lead product candidate is N91115, a small molecule that is in Phase II clinical trial, which addresses a defect in cystic fibrosis transmembrane conductance regulator (CFTR), resulting from mutations in the CFTR g... NVLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT